According to a new report North America Artificial Intelligence in Diagnostics Market, published by KBV research, the North America Artificial Intelligence in Diagnostics Market would witness market growth of 26.6% CAGR during the forecast period (2020-2026).
The USA market dominated the North America Cardiology Market by Country in 2019, and would continue to be a dominant market till 2026. The Canada market is experiencing a CAGR of 33.4% during (2020 - 2026). Additionally, The Mexico market would witness a CAGR of 36% during (2020 - 2026).
The Software market dominated the Canada Artificial Intelligence in Diagnostics Market in 2019. The Services market is estimated to grow at a CAGR of 33.5% during (2020 - 2026). Additionally, The Hardware market is exhibiting a CAGR of 31% during (2020 - 2026).
The Neurology market dominated the Mexico Artificial Intelligence in Diagnostics Market by Diagnosis Type in 2019, growing at a CAGR of 33.9 % during the forecast period. The Oncology market is expected to witness a CAGR of 34.3% during (2020 - 2026).
Report Structural Insights: https://www.kbvresearch.com/north-america-artificial-intelligence-diagnostics-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of General Electric (GE) Co. (GE Healthcare), Siemens AG (Siemens Healthineers), Aidoc Medical Ltd., AliveCor, Inc., Imagen Technologies, Inc., VUNO, Inc., IDx Technologies, Inc., NovaSignal Corporation, Riverain Technologies, LLC, and Zebra Medical Vision Ltd.
By Diagnosis Type
By Component
By Country
Companies Profiled
Unique Offerings from KBV Research
Unique Offerings 
